When did VITEK 2 AST-Gram Negative Cefazolin (= 32 µg/mL) receive FDA 510(k) clearance?

VITEK 2 AST-Gram Negative Cefazolin (= 32 µg/mL) received FDA 510(k) clearance on 2025-08-21, under 510(k) number K251579.

FDA 510(k)

VITEK 2 AST-革兰氏阴性头孢唑啉（=<1-=>32 µg/mL）

K号: K251579 · 2025-08-21

申请人bioMerieux, Inc.

决定日期2025-08-21

产品代码LON

咨询委员会抱歉，您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) is the device name listed in this FDA 510(k) record. The listed applicant is bioMerieux, Inc.. It received FDA 510(k) clearance on 2025-08-21 under 510(k) number K251579. The device is classified under product code LON. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)?

VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) is a medical device that received FDA 510(k) clearance on 2025-08-21. The listed applicant is bioMerieux, Inc.. The 510(k) number is K251579.

When did VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) receive FDA 510(k) clearance?

VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) received FDA 510(k) clearance on 2025-08-21, under 510(k) number K251579.

Who is the listed applicant for VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)?

The FDA 510(k) record lists bioMerieux, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)?

The FDA product code for VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) is LON.

列明bioMerieux, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K260160VITEK REVEAL GN AST 测定和 VITEK REVEAL AST 系统 K260282VITEK 2 AST-诱导克林霉素耐药性链球菌 K234012VITEK COMPACT PRO K232967VITEK 2 AST-酵母伏立康唑（<= 0.03125 - >= 4 µg/mL）K232963VITEK 2 AST-酵母阿尼鲁兰（<= 0.015 - >= 8 µg/mL）K240279VIDAS TBI（GFAP，UCH-L1）

查看所有 65 个设备 →

相关器械（代码：LON）

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K260282VITEK 2 AST-诱导克林霉素耐药性链球菌bioMerieux, Inc.K260281VITEK 2 AST-链球菌头孢呋辛（<=0.125 - >=8 µg/mL）BIOMERIEUX K251713BD Phoenix 自动微生物学系统 - GN 恩拉韦环素（0.125-2 µg/mL）Becton, Dickinson and Company K250447BD Phoenix® 自动微生物学系统 - GN 亚胺培南-雷巴匹坦（0.0625/4 - 16/4 µg/mL）Becton, Dickinson and Company K234012VITEK COMPACT PRObioMerieux, Inc.K250344BD Phoenix® 自动微生物学系统Becton, Dickinson and Company

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。